Category: Shanghai Green Valley Pharmaceutical Co. Ltd

/C O R R E C T I O N: Innovative Alzheimer’s Treatment from China Concludes Phase 3 Clinical Trials Green Valley plans to submit the application for treatment to the China National Drug Administration this Year SHANGHAI, July 19, 2018 /PRNewswire/ —  Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) today announced that its Phase 3 Study […]